Pharmaids Pharmaceuticals board meeting scheduled for May 29, 2026 to approve audited FY26 results.
Trading window closed for designated persons until 48 hours after results declaration.
Disclosure made under SEBI Listing Regulations Regulation 29 for compliance purposes.